Metraipolis › archive › dc_a63e87c8be17

Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA — Europe PMC PMID:41679923

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41679923
DOI
10.2967/jnumed.125.271231
License (as archived)
solo-consultazione
Archived
2026-11-02T20:10:51.777Z
SHA-256 of the archived text
2aed150f27d057bf406c426aae3ee6746c468b44406ee98c4332d99a4f7a92ea
Stable URL of this page
https://metraipolis.com/documento/dc_a63e87c8be17

How to cite

Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA — Europe PMC PMID:41679923 — Europe PMC (en), https://europepmc.org/article/MED/41679923 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a63e87c8be17 (Metraipolis archive dc_a63e87c8be17, sha256 2aed150f27d057bf406c426aae3ee6746c468b44406ee98c4332d99a4f7a92ea)
BibTeX
@misc{dca63e87c8be17,
  title = {Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA — Europe PMC PMID:41679923},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41679923},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a63e87c8be17; sha256 2aed150f27d057bf406c426aae3ee6746c468b44406ee98c4332d99a4f7a92ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41679923. Agents can read the archived copy with the MCP tool read_document.